Association between Anemia and COPD in Iranian Population
-
Roshanak Hasheminasab Zavarreh
,
Mohammad-Mehdi Zahmatkesh
,
Masood Vakili
,
Ali Shahriari-Ahmadi
,
Mohammad Ali Zohal
,
Mohsen Arabi
,
Alireza Mahmoudian
,
Abbas Gheisuri
,
Abdolhamed Kian
,
Ali Fahimi
Abstract
Background and Aim: Chronic obstructive pulmonary disease (COPD) is one of the major causes of morbidity and mortality in adults. Anemia is known as comorbidity in many chronic diseases that can increase morbidity and mortality of COPD. Recent studies have shown that anemia may be more prevalent than expected in COPD patients and can increase disabilities of COPD. In this study we have evaluated the correlation between anemia and the severity of COPD in patients referred to teaching hospitals of the Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Material and Method: In this cross-sectional study the severity of COPD in 760 patients with dyspnea who referred to teaching hospitals of Tehran University of Medical Sciences and 96 stable COPD patients were categorize using a GOLD criteria from mild to moderate, severe and very severe. Anemia was determined as hemoglobin <13 g/dL in men and <12 g/dL in women, respectively. Demographic characteristics, spirometry parameters and laboratory findings were compared between anemic and non-anemic groups using Student t-test and regression tests (SPSS v.18 software).
Results: The Mean age of patients was 65 ± 13.07 years (59.4% male). Overall prevalence of anemia was 27% and there was no correlation between severity of COPD and anemia. Anemic patients were significantly older than non-anemic patients (71.1 ± 8.5 years vs. 65.4± 12.8 years; p = 0.030). RBC count of anemic patients were significantly lower than non-anemic group (4.3 ± 0.5 vs. 5.02± 0.8 ×106/µL; p < 0.001). Erythropoietin levels in anemic group was significantly higher than non-anemic group (16.33±2.43 vs. 10.22 ± 2.67 mu/ml; p < 0.001) and there was a significant inverse correlation of hemoglobin vs erythropoietin (r= -0.8).
Conclusion: There was a high prevalence of anemia in COPD patients. Anemia can increase disabilities of COPD. Thus, treatment of anemia may improve quality of life in these patients. Further comprehensive studies are needed for determination of exact prevalence of anemia and its physiologic effects in COPD.
Krishnan G, Grant BJ, Muti PC, Mishra A, Ochs-Balcom HM, Freudenheim JL. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med. 2006 Sep 5; 6:23.
Almagro P, Calbo E, OchoadeEchaguen A, Mortality after hospitalization for COPD. Chest 2002; 121:1441–1448.
Gerardi DA, Lovett L, Benoit-ConnorsML, Reardon JZ, Zu Wallack RL. Variables related to increased mortality Following out-patient pulmonary rehabilitation. Eur Respir J 1996;9:431–435.
Hersh CP, DeMeo DL, Al-Ansari E, Predictors of survival in severe, early onset COPD. Chest 2004; 126:1443–1451.
Landbo C, Prescott E, LangeP, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronic obstructive Pulmonary disease. Am J Respir Crit Care Med 1999;160: 1856–1861.
John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest. 2005 Mar; 127(3):825-9.
Mascitelli L, Pezzetta F. Anemia and COPD. Chest. 2005 Oct; 128(4):3084.
Standardization of spirometry 1994 update, American thoracic society Amj Respiv erit care med 1995, 152 (3):7107-1136
Hurd s, pauwels R. Global initiative for chronic obstructive long diseases (GOLD) pulm pharmacol ther 2002,15(4):353-355.
Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Shorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease.Cost Eff Resour Alloc. 2006 Oct 16; 4:17.
American thoracic society standards for the diagnosis & care of patients with chronic obstructive pulmonary disease. Amj respircit care med. 1995; 152: 77-121.
Penninx BW, Pahor M, CesariM, etal. Anaemiais Associated with disability and decreased physical performance and muscle strength in the elderly. J Am Geriatr Soc 2004; 52:719–724.
Mansen TJ, McCance KL, Parker-Cohen PD. Alterations of erythrocyte function. In: McCance KL, Huether SE, eds. Pathophysiology. The Biologic Basis for Disease in Adults and Children. 2nd Edn. St.Louis, Mosby-Year BookInc., 1994;pp.860–877.
Reilly JJ, Edwin JR, Silverman K, et al. chronic obstructive pulmonary disease in: Braunwald, Fauci, Kasper et al (editors), Harrisons principals of internal medicine,18th ed, New York.Mc Graw hill 2012.p.1635-1643
Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007 May; 29(5):923-9.
John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol. 2006 Aug 28; 111(3):365-70.
Kilburn KH, Asmundsson T. Factors influencing the course of COPD. Postgrad Med. 1973 Sep; 54(3):135-41.
Shorr AF, Doyle J, Stern L, Dolgitser M, Zilberberg MD. Anemia in chronic obstructive pulmonary disease: epidemiology and economic implications. Curr Med Res Opin. 2008 Apr; 24(4):1123-30.
Similowski T, Agustí A, MacNee W, Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J. 2006 Feb; 27(2):390-6.
Chambellan A, Chailleux E, Similowski T; ANTADIR Observatory Group. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest. 2005 Sep; 128(3):1201-8.
Singh A. Is 13 g.dL(-1) the threshold to correct anaemia in COPD Eur Respir J. 2007;30(5):1024-5.
Pavlisa G, Vrbanic V, Kusec V, Jaksic B. Erythropoietin response after correction of severe hypoxaemia due to acute respiratory failure in chronic obstructive pulmonary disease patients. Clin Sci (Lond). 2004 Jan; 106(1):43-51.
Schols AM. Pulmonary cachexia. Int J Cardiol 2002; 85:101–110.
Means RT Jr. Advances in the anemia of chronic disease. Int J Hematol 1999; 70:7–12.
Marathias KP, Agroyannis B, Mavromoustakos T, et al.Hematocrit-lowering effect following inactivation of rennin angiotensin system with angiotensin converting enzymeinHibitors and angiotensin receptor blockers. Curr Top Med Chem2004;4:483–486
Ishani A, Weinhandl E, Zhao Z, et al. Angiotensin converting enzyme inhibitor as arisk factor for the development of anemia, and the impact of incident anemia on mortality in patients with Left ventricular dysfunction. Jam Coll Cardiol 2005;45:391–399
| Files | ||
| Issue | Vol 7, No 2 (2013) | |
| Section | Articles | |
| Keywords | ||
| Anemia COPD | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
